Geode Capital Management’s Ambit Biosciences Corp AMBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-45,200
Closed -$696K 4019
2014
Q3
$696K Buy
45,200
+10,122
+29% +$69.6K ﹤0.01% 2998
2014
Q2
$242K Sell
35,078
-61
-0.2% -$428 ﹤0.01% 3457
2014
Q1
$320K Buy
35,139
+8,096
+30% +$85.9K ﹤0.01% 3333
2013
Q4
$260K Buy
27,043
+1,175
+5% +$15.7K ﹤0.01% 3338
2013
Q3
$401K Buy
+25,868
New +$343K ﹤0.01% 3044

Geode Capital Management's AMBI Position: Q4 2014 in Review

Geode Capital Management sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 45,200 shares — an estimated $696K sold.

Geode Capital Management first reported a position in AMBI in Q3 2013 and held it in 5 quarters. The position peaked at $696K in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

  • Geode Capital Management reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
  • Geode Capital Management sold 45,200 Ambit Biosciences Corp shares in Q4 2014, an estimated $696K.
  • Geode Capital Management first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 5 quarters.
  • Geode Capital Management's Ambit Biosciences Corp position peaked at $696K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Geode Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.